Although US, CT, and MRI are all excellent modalities for the evaluation of hepatic and biliary disease, the imaging findings in COVID-19 may not be pathogen-specific, and findings are commonly nonspecific and subtle. At cross-sectional imaging, periportal edema and heterogeneity of the liver parenchyma should raise concern for hepatitis (Fig 16). Periportal edema may be more apparent at both CT and MRI (Fig 16). There has also been increased prevalence of hepatic steatosis in patients with COVID-19 that is likely attributable to the known association between infection and obesity (64). In fact, it has been reported that hepatic steatosis is an independent risk factor of severe disease (67).